Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: SVRA) | Delayed: 4.67 -0.09 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.76 | 52 Week High | $ | |||
| Open | $4.79 | 52 Week Low | $ | |||
| Day High | $4.95 | P/E | N/A | |||
| Day Low | $4.66 | EPS | $ | |||
| Volume | 2,086,103 | |||||
